Rapport Therapeutics, Inc. · NASDAQ:RAPP

Rapport Therapeutics, Inc. shareholders

As of Sep 30, 2026, 160 institutions reported holding Rapport Therapeutics, Inc., 84.9% of its shares. Largest: Fidelity, Trv Gp V, LLC and ARCH Venture Management, LLC. New holders, exits, insiders and big stakes, each with its filing.

HolderShares% of Rapport Therapeutics, Inc.ChangeFiled
Fidelity7.2M12.1%+23,763Nov 10, 2026
Trv Gp V, LLC6.28M10.6%no changeNov 16, 2026
ARCH Venture Management, LLC3.73M6.3%no changeNov 16, 2026
Capital Group3.21M5.4%−268KNov 12, 2026
Goldman Sachs2.97M5.0%+63,347Nov 16, 2026
BlackRock2.88M4.9%+181KNov 13, 2026
Cormorant Asset Management, LP2.46M4.1%−200KNov 16, 2026
Vanguard2.24M3.8%+280KNov 13, 2026
Sofinnova Investments, Inc.1.9M3.2%no changeNov 16, 2026
Johnson & Johnson1.78M3.0%no changeOct 26, 2026

Rapport Therapeutics, Inc. insider trades